The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat patients with earlier stages of the disease, drugmaker Novartis said Tuesday. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results